Your browser doesn't support javascript.
loading
Risperidone Related Raynaud's Phenomenon: An Adolescent Case.
Günes, Serkan; Ekinci, Özalp; Teke, Halenur; Yildirim, Veli.
Afiliação
  • Günes S; Department of Child and Adolescent Psychiatry, Hatay State Hospital, Hatay, Turkey.
  • Ekinci Ö; Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, Mersin, Turkey.
  • Teke H; Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, Mersin, Turkey.
  • Yildirim V; Department of Child and Adolescent Psychiatry, Mersin University School of Medicine, Mersin, Turkey.
Clin Psychopharmacol Neurosci ; 16(1): 118-121, 2018 Feb 28.
Article em En | MEDLINE | ID: mdl-29397675
ABSTRACT
Raynaud's phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake inhibitors, psychostimulants, and aripiprazole are reported to be related with Raynaud's phenomenon. Risperidone is an atypical antipsychotic drug with dopaminergic and serotonergic effects. In children and adolescents, risperidone is used for bipolar disorder, tic disorders, conduct disorder, schizophrenia, symptoms of irritability and self-mutilation. Here we report a case of Raynaud's phenomenon associated with risperidone in a 12-year-old boy. Raynaud's phenomenon occurred two weeks after starting risperidone and disappeared after stopping risperidone.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article